The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Antipsychotic Drug Use and Mortality in Older Adults with Dementia
Abstract
BACKGROUND: Antipsychotic drugs are widely used to manage behavioral and psychological symptoms in dementia despite concerns about their safety. OBJECTIVE: To examine the association between treatment with antipsychotics (both conventional and atypical) and all-cause mortality. DESIGN: Population-based, retrospective cohort study. SETTING: Ontario, Canada. PATIENTS: Older adults with dementia who were followed between 1 April 1997 and 31 March 2003. MEASUREMENTS: The risk for death was determined at 30, 60, 120, and 180 days after the initial dispensing of antipsychotic medication. Two pairwise comparisons were made: atypical versus no antipsychotic use and conventional versus atypical antipsychotic use. Groups were stratified by place of residence (community or long-term care). Propensity score matching was used to adjust for differences in baseline health status. RESULTS: A total of 27,259 matched pairs were identified. New use of atypical antipsychotics was associated with a statistically significant increase in the risk for death at 30 days compared with nonuse in both the community-dwelling cohort (adjusted hazard ratio, 1.31 [95% CI, 1.02 to 1.70]; absolute risk difference, 0.2 percentage point) and the long-term care cohort (adjusted hazard ratio, 1.55 [CI, 1.15 to 2.07]; absolute risk difference, 1.2 percentage points). Excess risk seemed to persist to 180 days, but unequal rates of censoring over time may have affected these results. Relative to atypical antipsychotic use, conventional antipsychotic use was associated with a higher risk for death at all time points. Sensitivity analysis revealed that unmeasured confounders that increase the risk for death could diminish or eliminate the observed associations. LIMITATIONS: Information on causes of death was not available. Many patients did not continue their initial treatments after 1 month of therapy. Unmeasured confounders could affect associations. CONCLUSIONS: Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia. The risk for death may be greater with conventional antipsychotics than with atypical antipsychotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A similar black box warning for conventional antipsychotics, based on two observational studies that showed increased risk of mortality in older adults using conventional versus atypical antipsychotics, was announced in 2008.117 118 119”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, it announced a black box warning for the use of atypical antipsychotics for behavioral and psychological symptoms of dementia.”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 2005, the FDA announced that, based on a re-analysis of 17 placebo controlled trials (several of which were unpublished), atypical antipsychotics were associated with a 1.7-fold increase in mortality compared with placebo.117 118”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A meta-analysis found an odds ratio for mortality with these drugs of 1.54 (1.06 to 2.23; Z=2.28; P=0.02), with pooled events of 3.5% mortality for the drug versus 2.3% for placebo.”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies have shown that nonpharmacological treatments pose fewer side effects, which render them as safer options [20].”
From Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review (2015) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Rosenbaum, P. R., & Rubin, D. B. (1985) · The American Statistician · doi:10.2307/2683903 · Cited by 6,472
Variable Selection for Propensity Score Models
Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S., Lebowitz, B. D., Lyketsos, C. G., Ryan, J. M., Stroup, T. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061240 · Cited by 1,206
Austin, P. C., Grootendorst, P. V., & Anderson, G. M. (2006) · Statistics in Medicine · doi:10.1002/sim.2580 · Cited by 1,138
Self-citationRisk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
Effectiveness of Collaborative Care for Older Adults With Alzheimer Disease in Primary Care
Callahan, C. M., Boustani, M. A., Unverzagt, F. W., Austrom, M. G., Damush, T. M., Perkins, A. J., Fultz, B. A., Hui, S. L., Counsell, S. R., & Hendrie, H. C. (2006) · JAMA · doi:10.1001/jama.295.18.2148 · Cited by 799
Research works printed but not linked: 4
- Levy AR, 2003, Can J Clin Pharmacol, 10, 67
- 10.1080/00031305.1985.10479383 · DOI
- Trifirò G, 2006, Pharmacoepidemiol Drug Saf
- Gill SS, 2006, JAMA, 295, 495
Cited by
Sorted by citations
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“An increased mortality risk has been associated with the use antipsychotics in older patients with dementia [1377-1379], which appears to be greater with conventional compared to atypical antipsychotics [1378-1380].”
BackgroundTreatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
Cummings, J. L., Tong, G., & Ballard, C. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180766 · Cited by 588
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 584
Maher, A. R., Maglione, M., Bagley, S., Suttorp, M., Hu, J.-H., Ewing, B., Wang, Z., Timmer, M., Sultzer, D., & Shekelle, P. G. (2011) · JAMA · doi:10.1001/jama.2011.1360 · Cited by 558
Pu, L., Moyle, W., Jones, C., & Todorovic, M. (2019) · The Gerontologist · doi:10.1093/geront/gny046 · Cited by 516
EFNS guidelines for the diagnosis and management of Alzheimer's disease
Hort, J., O’Brien, J. T., Gainotti, G., Pirttila, T., Popescu, B. O., Rektorova, I., Sorbi, S., Scheltens, P., & Dementia, O. B. O. T. E. S. P. O. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03040.x · Cited by 490
Increasing off‐label use of antipsychotic medications in the United States, 1995–2008
Alexander, G. C., Gallagher, S. A., Mascola, A. J., Moloney, R., & Stafford, R. S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2082 · Cited by 426
Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
Kales, H. C., Kim, H. M., Zivin, K., Valenstein, M., Seyfried, L. S., Chiang, C., Cunningham, F., Schneider, L. S., & Blow, F. C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030347 · Cited by 384
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Medication-Related Falls in the Elderly
Huang, A. R., Mallet, L., Rochefort, C. M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. M. (2012) · Drugs & Aging · doi:10.2165/11599460-000000000-00000 · Cited by 365
Patel, R. P., Gambrell, M., Speroff, T., Scott, T. A., Pun, B. T., Okahashi, J., Strength, C., Pandharipande, P. P., Girard, T. D., Burgess, H., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819b8608 · Cited by 319
Antidepressants for agitation and psychosis in dementia
Seitz, D. P., Adunuri, N., Gill, S. S., Gruneir, A., Herrmann, N., & Rochon, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008191.pub2 · Cited by 304
Self-citationBennet, A. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.598 · Cited by 281
Jøranson, N., Pedersen, I., Rokstad, A. M. M., & Ihlebæk, C. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.05.002 · Cited by 268
Huybrechts, K. F., Gerhard, T., Crystal, S., Olfson, M., Avorn, J., Levin, R., Lucas, J. A., & Schneeweiß, S. (2012) · BMJ · doi:10.1136/bmj.e977 · Cited by 264
Drug Burden Index Score and Functional Decline in Older People
Hilmer, S. N., Mager, D. E., Simonsick, E. M., Ling, S. M., Windham, B. G., Harris, T. B., Shorr, R. I., Bauer, D. C., & Abernethy, D. R. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.02.021 · Cited by 255
Oliveira, A. M. D., Radanovic, M., Mello, P. C. H. D., Buchain, P. C., Vizzotto, A. D. B., Celestino, D. L., Stella, F., Piersol, C. V., & Forlenza, O. V. (2015) · BioMed Research International · doi:10.1155/2015/218980 · Cited by 247
Impact of FDA Black Box Advisory on Antipsychotic Medication Use
Dorsey, E. R. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.456 · Cited by 243
Antipsychotics for treatment of delirium in hospitalised non-ICU patients
Burry, L., Mehta, S., Perreault, M. M., Luxenberg, J. S., Siddiqi, N., Hutton, B., Fergusson, D. A., Bell, C., & Rose, L. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005594.pub3 · Cited by 237
Self-citationAntipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia
Rochon, P. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.10.1090 · Cited by 242
Self-citationPage, R. L., II (2010) · Clinical Interventions in Aging · doi:10.2147/cia.s9564 · Cited by 223
Rodda, J. E., Morgan, S., & Walker, Z. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209990354 · Cited by 218
Atypical Antipsychotic Use in Patients With Dementia: Managing Safety Concerns
Steinberg, M., & Lyketsos, C. G. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030342 · Cited by 216
Pharmacological interventions for the treatment of delirium in critically ill adults
Burry, L. D., Hutton, B., Williamson, D. R., Mehta, S., Adhikari, N. K. J., Cheng, W., Ely, E. W., Egerod, I., Fergusson, D. A., & Rose, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011749.pub2 · Cited by 180
Dementia of the Alzheimer Type
Jalbert, J. J., Daiello, L. A., & Lapane, K. L. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn008 · Cited by 181
Antipsychotic drugs and risk of venous thromboembolism: nested case-control study
Parker, C., Coupland, C. A. C., & Hippisley‐Cox, J. (2010) · BMJ · doi:10.1136/bmj.c4245 · Cited by 172
Seitz, D. P., Brisbin, S., Herrmann, N., Rapoport, M. J., Wilson, K., Gill, S. S., Rines, J., LeClair, K., & Conn, D. K. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.12.059 · Cited by 169
Self-citationTrends in Antipsychotic Use in Dementia 1999-2007
Kales, H. C., Zivin, K., Kim, H. M., Valenstein, M. M., Chiang, C., Ignacio, R. V., Ganoczy, D. A., Cunningham, F. E., Schneider, L. S. S., & Blow, F. C. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.200 · Cited by 172
Association of Community-Acquired Pneumonia With Antipsychotic Drug Use in Elderly Patients
Trifirò, G., Gambassi, G., Sen, E. F., Caputi, A. P., Bagnardi, V., Brea, J. M., & Sturkenboom, M. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-7-201004060-00006 · Cited by 165
Ralph, S. J., & Espinet, A. J. (2018) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-170042 · Cited by 160
Efficacy of music therapy treatment based on cycles of sessions: A randomised controlled trial
Raglio, A., Bellelli, G., Traficante, D., Gianotti, M., Ubezio, M. C., Gentile, S., Villani, D., & Trabucchi, M. (2010) · Aging & Mental Health · doi:10.1080/13607861003713158 · Cited by 160
Watt, J. A., Goodarzi, Z., Veroniki, A. A., Nincic, V., Khan, P. A., Ghassemi, M., Thompson, Y., Tricco, A. C., & Straus, S. E. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0993 · Cited by 159
CNODES: the Canadian Network for Observational Drug Effect Studies.
Suissa, S., Henry, D. A., Caetano, P. A., Dormuth, C. R., Ernst, P., Hemmelgarn, B. R., LeLorier, J., Levy, A. R., Martens, P. J., Paterson, J. M., et al. (2012) · Europe PMC (PubMed Central) · Cited by 153
Incidence of dementia in older adults with intellectual disabilities
Strydom, A., Chan, T., King, M., Hassiotis, A., & Livingston, G. (2013) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2013.02.021 · Cited by 147
Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease
Herrmann, N., & Gauthier, S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.070804 · Cited by 140
Self-citationMittal, V., Kurup, L., Williamson, D. E., Muralee, S., & Tampi, R. R. (2011) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317510390351 · Cited by 145
Ng, R., Lane, N. E., Tanuseputro, P., Mojaverian, N., Talarico, R., Wodchis, W. P., Bronskill, S. E., & Hsu, A. T. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16394 · Cited by 135
Self-citationKnowledge translation research: the science of moving research into policy and practice.
Curran, J., Grimshaw, J., Hayden, J., & Campbell, B. (2011) · Journal of Continuing Education in the Health Professions · doi:10.1002/chp.20124 · Cited by 130
Pharmacological and Nonpharmacological Management of Delirium in Critically Ill Patients
Hipp, D. M., & Ely, E. W. (2012) · Neurotherapeutics · doi:10.1007/s13311-011-0102-9 · Cited by 134
Richter, T., Mann, E., Meyer, G., Haastert, B., & Köpke, S. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.03.007 · Cited by 132
Yang, M.-H., Lin, L.-C., Wu, S.-C., Chiu, J.-H., Wang, P.-N., & Lin, J.-G. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0612-9 · Cited by 123
Seitz, D. P., Gill, S. S., Herrmann, N., Brisbin, S., Rapoport, M. J., Rines, J., Wilson, K., LeClair, K., & Conn, D. K. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212001627 · Cited by 130
Self-citationSeitz, D. P., Gill, S. S., Gruneir, A., Austin, P. C., Anderson, G., Bell, C. M., & Rochon, P. A. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.12.011 · Cited by 122
Self-citationGeorge, J., Long, S. J., & Vincent, C. A. (2013) · Journal of the Royal Society of Medicine · doi:10.1177/0141076813476497 · Cited by 121
Cohen‐Mansfield, J., Marx, M. S., Dakheel‐Ali, M., Regier, N. G., Thein, K., & Freedman, L. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02951.x · Cited by 120
Daily Medication Use in Nursing Home Residents with Advanced Dementia
Tjia, J., Rothman, M. R., Kiely, D. K., Shaffer, M. L., Holmes, H. M., Sachs, G. A., & Mitchell, S. L. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02819.x · Cited by 122
Mok, P. L. H., Carr, M., Guthrie, B., Morales, D. R., Sheikh, A., Elliott, R. A., Camacho, E. M., van Staa, T. P., Avery, A. J., & Ashcroft, D. M. (2024) · BMJ · doi:10.1136/bmj-2023-076268 · Cited by 133
Rabinovici, G. D. (2019) · Continuum · doi:10.1212/con.0000000000000700 · Cited by 170
Frontotemporal lobar degeneration: current perspectives
Kurz, A., Riedl, L., Mackenzie, I. R., Förstl, H., & Diehl‐Schmid, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s38706 · Cited by 123
Valiyeva, E., Herrmann, N., Rochon, P. A., Gill, S. S., & Anderson, G. M. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071540 · Cited by 113
Self-citationThe burden of psychotropic drug prescribing in people with dementia: a population database study
Guthrie, B., Clark, S. A., & McCowan, C. (2010) · Age and Ageing · doi:10.1093/ageing/afq090 · Cited by 113
Tourism as a dementia treatment based on positive psychology
Wen, J., Zheng, D., Hou, H.-F., Phau, I., & Wang, W. (2022) · Tourism Management · doi:10.1016/j.tourman.2022.104556 · Cited by 106
Huybrechts, K. F., Rothman, K. J., Silliman, R. A., Brookhart, A. M., & Schneeweiß, S. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101406 · Cited by 115
Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis
Weintraub, D. A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.139 · Cited by 112
Exploring Variation in Rates of Polypharmacy Across Long Term Care Homes
Bronskill, S. E., Gill, S. S., Paterson, J. M., Bell, C. M., Anderson, G., & Rochon, P. A. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.07.001 · Cited by 110
Self-citationIjaopo, E. O. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.199 · Cited by 114
Stevenson, D. G., Decker, S. L., Dwyer, L. L., Huskamp, H. A., Grabowski, D. C., Metzger, E. D., & Mitchell, S. L. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181d6c0c6 · Cited by 111
A European Academy of Neurology guideline on medical management issues in dementia
Frederiksen, K. S., Cooper, C., Frisoni, G. B., Frölich, L., Georges, J., Kramberger, M. G., Nilsson, C., Passmore, P., Ritter, L. M., Religa, D., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14412 · Cited by 106
Antipsychotic Use and the Risk of Hip Fracture Among Older Adults Afflicted With Dementia
Jalbert, J. J., Eaton, C. B., Miller, S. C., & Lapane, K. L. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2009.10.001 · Cited by 105
The Treatment of Alzheimer Disease
Winslow, B. T., Onysko, M. K., Stob, C. M., & Hazlewood, K. A. (2008) · Springer eBooks · doi:10.1007/978-3-540-87523-9_6 · Cited by 100
Effectiveness of Companion Robot Care for Dementia: A Systematic Review and Meta-Analysis
Lu, L., Lan, S., Hsieh, Y., Lin, L., Lan, S., & Chen, J. (2021) · Innovation in Aging · doi:10.1093/geroni/igab013 · Cited by 110
Setoguchi, S., Wang, P. S., Brookhart, M. A., Canning, C. F., Kaci, L., & Schneeweiß, S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01839.x · Cited by 100
Length of hospital stay and dementia: A systematic review of observational studies
Möllers, T., Stocker, H. R., Wei, W., Perna, L., & Brenner, H. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4993 · Cited by 99
Risk of cerebrovascular events in elderly users of antipsychotics
Kleijer, B., van Marum, R. J., Egberts, T. C. G., Jansen, P. A. F., Knol, W., & Heerdink, E. R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093583 · Cited by 98
Trifirò, G., Spina, E., & Gambassi, G. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.017 · Cited by 95
Oderda, L. H., Young, J. R., Asche, C. V., & Pepper, G. A. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q589 · Cited by 94
Gallini, A., Andrieu, S., Donohue, J. M., Oumouhou, N., Lapeyre‐Mestre, M., & Gardette, V. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.003 · Cited by 99
Managing Behavioral and Psychological Symptoms of Dementia
Gerlach, L. B., & Kales, H. C. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.10.010 · Cited by 95
Delirium in the intensive care unit
Morandi, A., Jackson, J. C., & Ely, E. W. (2009) · International Review of Psychiatry · doi:10.1080/09540260802675296 · Cited by 100
Packages of Care for Dementia in Low- and Middle-Income Countries
Prince, M. J., Acosta, D. M., Costa, E., Jackson, J., & Shaji, K. S. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000176 · Cited by 97
Psychotropic medication use among nursing home residents in Austria: a cross-sectional study
Mann, E., Köpke, S., Haastert, B., Pitkälä, K. H., & Meyer, G. (2009) · BMC Geriatrics · doi:10.1186/1471-2318-9-18 · Cited by 94
Rikala, M., Hartikainen, S. A., Sulkava, R. O., & Korhonen, M. J. (2010) · Drugs & Aging · doi:10.2165/11315960-000000000-00000 · Cited by 89
Danielsson, B. R. G., Collin, J., Jonasdottir, G., Borg, N., Salmi, P., & Fastbom, J. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12829 · Cited by 89
Comparative mortality risks of antipsychotic medications in community-dwelling older adults
Gerhard, T., Huybrechts, K. F., Olfson, M., Schneeweiß, S., Bobo, W. V., Doraiswamy, P. M., Devanand, D. P., Lucas, J. A., Huang, C. Y., Malka, E. S., et al. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.122499 · Cited by 86
Okahara, K., Ishida, Y., Hayashi, Y., Inoue, T., Tsuruta, K., Takeuchi, K., Yoshimuta, H., Kiue, K., Ninomiya, Y., Kawano, J., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.02.013 · Cited by 86
Patterns of Antipsychotic Medication Use in Australia 2002–2007
Hollingworth, S., Siskind, D. J., Nissen, L. M., Robinson, M., & Hall, W. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903489890 · Cited by 86
Testing Family-Centered, Function-Focused Care in Hospitalized Persons with Dementia
Boltz, M., Chippendale, T., Resnick, B., & Galvin, J. E. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.10 · Cited by 85
What is the therapeutic value of antidepressants in dementia? A narrative review
Farina, N., Morrell, L., & Banerjee, S. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4566 · Cited by 87
Langballe, E. M., Engdahl, B., Nordeng, H., Ballard, C. G., Aarsland, D., & Selbæk, G. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.06.007 · Cited by 88
Psychosocial interventions for reducing antipsychotic medication in care home residents
Richter, T., Meyer, G., Mohler, R. A., & Köpke, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008634.pub2 · Cited by 87
Identification and Management of In-Hospital Drug-Induced Delirium in Older Patients
Catic, A. (2011) · Drugs & Aging · doi:10.2165/11592240-000000000-00000 · Cited by 83
Jutkowitz, E., Brasure, M., Fuchs, E. L., Shippee, T. P., Kane, R. A., Fink, H. A., Butler, M. E., Sylvanus, T., & Kane, R. L. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13936 · Cited by 88
Antipsychotic drug use and pneumonia: Systematic review and meta-analysis
Dzahini, O., Singh, N., Taylor, D. M., & Haddad, P. M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118795333 · Cited by 82
Tamblyn, R. M., Eguale, T., Buckeridge, D. L., Huang, A. R., Hanley, J., Reidel, K. E., Shi, S., & Winslade, N. E. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000609 · Cited by 83
Predictors of Mortality in Dementia: The PRIME Study
Connors, M. H., Ames, D., Boundy, K., Clarnette, R., Kurrle, S., Mander, A., Ward, J., Woodward, M., & Brodaty, H. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150946 · Cited by 81
Non-Pharmacologic Interventions for Persons with Dementia.
Berg‐Weger, M., & Stewart, D. B. (2017) · Europe PMC (PubMed Central) · Cited by 79
Incomplete response in late-life depression: getting to remission
Lenze, E. J., Sheffrin, M., Driscoll, H. C., Mulsant, B. H., Pollock, B. G., Dew, M. A., Lotrich, F., Devlin, B., Bies, R. R., & Reynolds, C. F. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/jlenze · Cited by 79
Comparative Safety of Antipsychotic Medications in Nursing Home Residents
Huybrechts, K. F., Schneeweiß, S., Gerhard, T., Olfson, M., Avorn, J., Levin, R., Lucas, J. A., & Crystal, S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03853.x · Cited by 80
Withholding, Discontinuing and Withdrawing Medications in Dementia Patients at the End of Life
Parsons, C., Hughes, C. M., Passmore, A. P., & Lapane, K. L. (2010) · Drugs & Aging · doi:10.2165/11536760-000000000-00000 · Cited by 78
Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors
Nørgaard, A., Jensen‐Dahm, C., Gasse, C., Hansen, E. S., & Waldemar, G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160828 · Cited by 80
Antipsychotics in the Treatment of Delirium in Older Hospitalized Adults: A Systematic Review
Flaherty, J. H., Gonzales, J. P., & Dong, B. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03675.x · Cited by 77
Leonard, C. E. (2012) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.s10-006 · Cited by 77
Antipsychotic Use and Myocardial Infarction in Older Patients With Treated Dementia
Fourrier-Réglat, A. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.28 · Cited by 75
Antipsychotic Drugs and Hyperglycemia in Older Patients With Diabetes
Lipscombe, L. L., Lévesque, L. E., Gruneir, A., Fischer, H. D., Juurlink, D. N., Gill, S. S., Herrmann, N., Hux, J. E., Anderson, G., & Rochon, P. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.207 · Cited by 75
Self-citationTreatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study
Koller, D., Hua, T., & Bynum, J. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14226 · Cited by 75
Taipale, H. T., Koponen, M., Tanskanen, A. J., Tolppanen, A., Tiihonen, J., & Hartikainen, S. A. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.10.004 · Cited by 73
Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study
Connors, M. H., Ames, D. J., Woodward, M., & Brodaty, H. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.10.011 · Cited by 72
Fashaw‐Walters, S. A., Thomas, K. S., McCreedy, E. M., & Mor, V. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.07.004 · Cited by 75
Oh, E. S., & Rabins, P. V. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201909030 · Cited by 77
Metadata
- Authors
- Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., Gurwitz, J. H., & Rochon, P. A.
- Affiliations
- Harvard University (US)
- From Queen's University, Kingston, Ontario, Canada; Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Ontario, Canada; Harvard Medical School and Harvard School of Public Health, Boston, Massachusetts; University of British Columbia, Vancouver, British Columbia, Canada; and Meyers Primary Care Institute of the University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, Massachusetts.
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-06-05
- Volume
- 146
- Issue
- 11
- Pages
- 775-786
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2144855317
- Cited by
- 624
- References
- 66
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 22 · 2022: 30 · 2021: 18 · 2020: 27 · 2019: 31 · 2018: 38 · 2017: 36 · 2016: 45 · 2015: 42 · 2014: 30 · 2013: 37 · 2012: 35
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- antipsychotic drugs, atypical antipsychotics, typical antipsychotics, dementia, all-cause mortality, older adults, behavioral and psychological symptoms of dementia, long-term care, community-dwelling older adults, drug safety
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Humans, Male, Ontario, Sensitivity and Specificity, Time Factors, Antipsychotic Agents, Matched-Pair Analysis, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
